Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The “RNA binding protein, fox-1 homolog 1 pseudogene” (ENSG00000284728) is a nonfunctional genomic DNA segment related to the functional RBFOX1 gene. Pseudogenes typically arise from duplication or retrotransposition of their parent gene, losing the ability to encode functional protein due to accumulating mutations or lack of regulatory elements. Unlike the RBFOX1 gene—a splicing factor with crucial roles in neurodevelopment and alternative splicing—this pseudogene lacks demonstrated biological activity and clinical relevance. As a pseudogene, it is not a therapeutically actionable target and holds no recognized biomedical function or disease association[2][5][7][8].
None for the pseudogene; it does not produce protein or exert biological effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA binding protein, fox-1 homolog 1 pseudogene (None standardized).